Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development
作者： Li Yan , Robert A. Beckman
DOI: 10.2144/000112043
关键词: Oncology 、 Trastuzumab 、 Biomarker discovery 、 Medicine 、 Epidermal growth factor receptor 、 Internal medicine 、 Pharmacogenetics 、 Pharmacogenomics 、 Cetuximab 、 Rituximab 、 Personalized medicine
摘要: … review, we will focus on the application of pharmacogenetics and pharmacogenomics in developing monoclonal antibody (… MAb development and may guide clinical development and …
future-science.com
unirioja.es
biotechniques.com 
researchgate.net 参考文章(42)
Paul Carter, Improving the efficacy of antibody-based cancer therapies Nature Reviews Cancer. ,vol. 1, pp. 118- 129 ,(2001) , 10.1038/35101072
Arthur I Sagalowsky, David Euhus, Peter Beitsch, Larry Morrison, Chandra Rao, Nancy Lane, Jonathan Uhr, Songdong Meng, Edward Clifford, Hossein Saboorian, Thomas Tucker, B. Michael Ghadimi, Thomas Ried, Tanja Fehm, Kerstin Heselmeyer-Haddad, Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clinical Cancer Research. ,vol. 8, pp. 2073- 2084 ,(2002)
Peter Sondermann, Robert Huber, Vaughan Oosthuizen, Uwe Jacob, The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature. ,vol. 406, pp. 267- 273 ,(2000) , 10.1038/35018508
Michael F. Press, Dennis J. Slamon, Kerry J. Flom, Jinha Park, Jian-Yuan Zhou, Leslie Bernstein, Evaluation of HER-2/neu Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer Specimens Journal of Clinical Oncology. ,vol. 20, pp. 3095- 3105 ,(2002) , 10.1200/JCO.2002.09.094
Sébastien Dall’Ozzo, Sophie Tartas, Gilles Paintaud, Guillaume Cartron, Philippe Colombat, Pierre Bardos, Hervé Watier, Gilles Thibault, Rituximab-Dependent Cytotoxicity by Natural Killer Cells: Influence of FCGR3A Polymorphism on the Concentration-Effect Relationship Cancer Research. ,vol. 64, pp. 4664- 4669 ,(2004) , 10.1158/0008-5472.CAN-03-2862
Wen-Kai Weng, Ronald Levy, Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma Journal of Clinical Oncology. ,vol. 21, pp. 3940- 3947 ,(2003) , 10.1200/JCO.2003.05.013
Mark D. Pegram, Giovanni Pauletti, Dennis J. Slamon, Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy Breast Cancer Research and Treatment. ,vol. 52, pp. 65- 77 ,(1998) , 10.1023/A:1006111117877
Carlos J. Miranda, Hortence Makui, Ricardo J. Soares, Marc Bilodeau, Jeannie Mui, Hajatollah Vali, Richard Bertrand, Nancy C. Andrews, Manuela M. Santos, Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. Blood. ,vol. 102, pp. 2574- 2580 ,(2003) , 10.1182/BLOOD-2003-03-0869
Elizabeth L. Wiley, Leslie K. Diaz, High-Quality HER-2 Testing JAMA. ,vol. 291, pp. 2019- 2020 ,(2004) , 10.1001/JAMA.291.16.2019
Christopher D.M. Fletcher, Heikki Joensuu, George D. Demetri, Margaret von Mehren, Charles D. Blanke, Annick D. Van den Abbeele, Burton Eisenberg, Peter J. Roberts, Michael C. Heinrich, David A. Tuveson, Samuel Singer, Milos Janicek, Jonathan A. Fletcher, Stuart G. Silverman, Sandra L. Silberman, Renaud Capdeville, Beate Kiese, Bin Peng, Sasa Dimitrijevic, Brian J. Druker, Christopher Corless, Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. The New England Journal of Medicine. ,vol. 347, pp. 472- 480 ,(2002) , 10.1056/NEJMOA020461